Document Type
Poster
Publication Date
5-2012
Abstract
Atrophic changes have been proposed as biomarkers for differential diagnosis of Alzheimer's disease (AD) and amnestic mild cognitive impairment (MCI), and different atrophic rates have been observed in AD, MCI-tp-AD converters (cMRI), stable MCI (sMCI), and normal healthy controls[1]. Measurement of atrophic changes, however, requires longitudinal MRI studies. The purpose of this study was to investigate the following questions: 1. Is it possible to use baseline volumetric MRI to predict MCI conversion to AD, i.e., to tell if a MCI patient is a cMCI or a sMCI? 2. What are the predictive values of APOE genotype, and clinical cognitive test scores?
Recommended Citation
Lai, Song and Lackey, John, "Predictive Prognosis Value of Baseline Volumetric MRI" (2012). Department of Radiology Faculty Papers. Paper 22.
https://jdc.jefferson.edu/radiologyfp/22
Comments
This poster was presented at the 20th Annual Meeting and Exhibition of the ISMRM in Melbourne, Australia in 2012.